49 related articles for article (PubMed ID: 31449814)
1. Stable Monomeric Insulin Formulations Enabled by Supramolecular PEGylation of Insulin Analogues.
Maikawa CL; Smith AAA; Zou L; Meis CM; Mann JL; Webber MJ; Appel EA
Adv Ther (Weinh); 2020 Jan; 3(1):. PubMed ID: 32190729
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Assessment of Protein and Excipient Stability in Biopharmaceutical Formulations Using
Bramham JE; Podmore A; Davies SA; Golovanov AP
ACS Pharmacol Transl Sci; 2021 Feb; 4(1):288-295. PubMed ID: 33659867
[TBL] [Abstract][Full Text] [Related]
3. Biorelevant subcutaneous in vitro test predicts the release of human and fast acting insulin formulations.
Schöner TA; Vogel V; Venczel M; Knoth K; Kamm W; Paehler T; Louit G; Terán IT; Mundinger P; Marker A; Loos P; Hittinger M; Lehr CM
Int J Pharm; 2024 Apr; 655():123995. PubMed ID: 38490402
[TBL] [Abstract][Full Text] [Related]
4. Aggregation Behavior of Structurally Similar Therapeutic Peptides Investigated by
Hjalte J; Hossain S; Hugerth A; Sjögren H; Wahlgren M; Larsson P; Lundberg D
Mol Pharm; 2022 Mar; 19(3):904-917. PubMed ID: 35104408
[TBL] [Abstract][Full Text] [Related]
5. SAXS Reveals the Stabilization Effects of Modified Sugars on Model Proteins.
Piccinini A; Lourenço EC; Ascenso OS; Ventura MR; Amenitsch H; Moretti P; Mariani P; Ortore MG; Spinozzi F
Life (Basel); 2022 Jan; 12(1):. PubMed ID: 35054516
[TBL] [Abstract][Full Text] [Related]
6. New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals.
Jarosinski MA; Chen YS; Varas N; Dhayalan B; Chatterjee D; Weiss MA
J Clin Endocrinol Metab; 2022 Mar; 107(4):909-928. PubMed ID: 34850005
[TBL] [Abstract][Full Text] [Related]
7. Structural principles of insulin formulation and analog design: A century of innovation.
Jarosinski MA; Dhayalan B; Chen YS; Chatterjee D; Varas N; Weiss MA
Mol Metab; 2021 Oct; 52():101325. PubMed ID: 34428558
[TBL] [Abstract][Full Text] [Related]
8. Quality Assurance of Commercial Insulin Formulations: Novel Assay Using Infrared Spectroscopy.
Delbeck S; Heise HM
J Diabetes Sci Technol; 2021 Jul; 15(4):865-873. PubMed ID: 32281880
[TBL] [Abstract][Full Text] [Related]
9. NMR spectroscopy as a characterization tool enabling biologics formulation development.
Ma J; Pathirana C; Liu DQ; Miller SA
J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
[TBL] [Abstract][Full Text] [Related]
10. Insulin biosimilars: the impact on rapid-acting analogue-based therapy.
Franzè S; Cilurzo F; Minghetti P
BioDrugs; 2015 Apr; 29(2):113-21. PubMed ID: 25773234
[TBL] [Abstract][Full Text] [Related]
11. Profiling Insulin Oligomeric States by
Falk BT; Liang Y; McCoy MA
J Pharm Sci; 2020 Jan; 109(1):922-926. PubMed ID: 31449814
[TBL] [Abstract][Full Text] [Related]
12. Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature.
Teska BM; Alarcón J; Pettis RJ; Randolph TW; Carpenter JF
J Pharm Sci; 2014 Aug; 103(8):2255-67. PubMed ID: 24909933
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic fibrillation of fast-acting insulin analogs.
Woods RJ; Alarcón J; McVey E; Pettis RJ
J Diabetes Sci Technol; 2012 Mar; 6(2):265-76. PubMed ID: 22538135
[TBL] [Abstract][Full Text] [Related]
14. Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation.
Gast K; Schüler A; Wolff M; Thalhammer A; Berchtold H; Nagel N; Lenherr G; Hauck G; Seckler R
Pharm Res; 2017 Nov; 34(11):2270-2286. PubMed ID: 28762200
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
